Aytu Biopharma Inc expected to post a loss of 49 cents a share - Earnings Preview

Aytu Biopharma

13/11/2021 24:22

* Aytu Biopharma Inc  AYTU.OQ   AYTU.O  is expected to show a
rise in quarterly revenue when it reports  results on November
15. 
* The Englewood, Colorado-based company is expected to report  a
63.5% increase in revenue to $22.1 million from $13.52 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Aytu Biopharma Inc is
for a loss of 49 cents per share. For the same quarter last
year, the company reported a loss of 40 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Aytu Biopharma
Inc is $17.5​, about 85.9% above​ its last closing price
of $2.47. ​​​
This summary was machine generated November 13 at 00:22 GMT. 
All figures in US dollars  unless otherwise stated